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In recent years the understanding of the mechanisms that lead to immune
deposits in renal glomeruli has improved . The lattice of circulating antigen-
antibody complexes influences the deposition of these substances in the suben-
dothelial and mesangial areas in glomeruli. Electron-dense immune deposits
evolved in subendothelial and mesangial areas when large-latticed immune
complexes, defined as containing more than two antibody molecules (greater
than Ag2Ab2), were injected into mice (1). When small-latticed immune com-
plexes (Ag,Ab, and Ag2Ab2)were injected, electron-dense deposits did notevolve
(2). When the already deposited large-latticed complexes in glomeruli were
exposed to large excess of antigen in vivo to convert them into small-latticed
complexes, the deposits were released from glomeruli (3). Finally, even the
soluble, large-latticed immune complexes had to undergo rearrangement or
condensation into even larger immune complexes to persist in glomeruli and to
become electron-dense deposits (4). These observations collectively indicate that
the development ofsubendothelial and mesangial electron-dense immune depos-
its requires a precipitating antigen-antibody system.
The development ofsubepithelial antigen-antibody deposits isthought to occur
principally by local immune complex formation, as reviewed by Couser and
Salant (5). The recognition offixed negative charges in the glomerular capillary
wall (6-8) led to a series of experiments documenting that positively charged
antigenic molecules were planted in the subepithelial area of glomeruli (9-11) .
When specific antibodies were injected into these animals, immune deposits and
electron-dense deposits formed and persisted for days (12-14). The lattice
requirements for the development of subepithelial electron-dense immune de-
posits has not been examined.
The experiments described in this article used cationized precipitating or
nonprecipitating antigens, constructedby varyingthe hapten densityon a carrier
molecule, to show that a precipitating antigen-antibody system is required for
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the development of electron-dense immune deposits in the subepithelial area of
rat glomeruli. The nonprecipitating immune complexes persisted for a short
period of time by immunofluorescence microscopy comparable to the cationized
antigen alone, and the presence of these complexes was not detectable by electron
microscopy.
Materials and Methods
Preparation of Antigens and Antibodies.
￿
Human serum albumin (HSA)' (Miles/Pentex,
Kankakee, IL) was purified by ion exchange chromatography and gel filtration. Twice
recrystallized 4-fluoro-3-nitroaniline (Aldrich Chemical Co., Milwaukee, WI) was con-
verted to 4-fluoro-3-nitrophenyl azide and conjugated to HSA by previously described
methods (15) to yield nitroazidophenyl HSA (NAP - HSA). The average degree of conju-
gation of the hapten to HSA was determined by amino acid analysis (AAA Laboratory,
Seattle, WA). Since a precipitating antigen-antibody system was achieved with NAP - HSA
preparations when the average hapten density exceeded 13 (16), three conjugates were
prepared, NAP3..1 -HSA, NAP, 1.4 .HSA as nonprecipitating antigens and NAP19.7 -HSA
as a precipitating antigen. These calculations were based on the presence of 58 lysines in
HSA (17). The concentrations of NAP - HSA preparations were determined with the Bio-
Rad protein assay (Bio-Rad Laboratories, Richmond, CA) (18) using HSA as a standard,
since the NAP group does not interfere with this reaction. The NAP - HSA preparations
were protected from light with aluminum foil around the containers or columns because
the aryl azide is photosensitive.
NAP - HSA preparations were cationized by previously described methods with some
modifications (19). The NAP - HSA preparations were dialyzed into 0 .2 M phosphate
buffer, pH 6.0 . Ethylene diamine (340 /,l) was added to 7 .0 ml of the same phosphate
buffer with stirring and the pH was adjusted to 6 .0 with 12 M HCl, and the volume was
brought to 10 ml with the phosphate buffer. Then 20 mg of protein in 3.0 ml was added,
followed with 400 mg of EDAC [ 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide HCl;
Sigma Chemical Co., St., Louis, MO] and the mixture incubated at room temperature for
30 min. The reaction mixture was then extensively dialyzed against 0.2 M sodium borate,
0.15 M NaCl, pH 8.0, buffer. Monomeric, cationized antigen was obtained by gel filtration
over Sephadex G-100 (Pharmacia Fine Chemicals, Piscataway, NJ). The cationized anti-
gens were designated NAP3.1 -HSAED, NAP, 1.4 .HSAED, and NAP,9.7-HSAED. The flat bed
Pharmacia isoelectric focusing system (Pharmacia Fine Chemicals) was used to characterize
the degree of cationization of antigens, as previously described (19) .
Antibodiesto the NAP haptenic group were obtained by immunizing rabbits with NAP-
keyhole limpet hemocyanin. The antiserum was heated to 56°C for 30 min to inactivate
complement, and antibodies to NAP (antiNAP) were isolated with affinity chromatography
as previously described (20), using NAP - HSA affinity columns. Antibodies to HSA were
obtained by immunizing rabbits with HSA in complete Freund's adjuvant. The specific
antibodies were isolated by affinity chromatography as previously described (20). The
antibody preparations were gel filtered on Sephadex G-200 columns (Pharmacia Fine
Chemicals) to obtain monomeric preparations.
Double immunodiffusion was carried out, as described by Ouchterlony (21), to deter-
mine the precipitability of the antigen-antibody systems. Agarose IEF (Pharmacia Fine
Chemicals) was used to construct the gels to permit free diffusion of the cationic antigens.
Radioiodination of antigens or antibodies with"I or "'I was carried out by the iodine
monochloride method (22), yielding specific activities of 1 .5-2.0 A.Ci/mg of protein .
Sucrose density gradient ultracentrifugation for characterization of the lattice of immune
' Abbreviations used in this paper: antiHSA, rabbit antibodies to human serum albumin; antiNAP,
antibodies to the nitroazidophenyl haptenic group; ED, ethylene diamine treated for cationization;
EDAC, I-ethyl-3-(3-dimethylamino-propyl)carbodiimide HCI; HSA, human serum albumin; NAP, 2-
nitro-4-azidophenyl; NAP -HSA, nitroazidophenyl human serum albumin; the subscript after NAP
designates the average number of the haptenic groups in HSA.AGODOA ET AL.
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complexes was conducted on 10-30% linear sucrose gradients as previously described
(20).
Animal Experiments.
￿
Lewis or Sprague-Dawley rats weighing 350-450 g were used.
Anesthesia was achieved with intramuscular 0.2 ml of 1 :5 dilution of Inovar-vet (McNeil
Laboratories, Inc., Fort Washington, PA). All injections of antigen were given directly
into the left renal artery. For this purpose a midline abdominal incision was made with
rats under anesthesia. The left renal artery was then exposed, and 0 .5 ml of borate buffer
was used to flush the left kidney through a 25-gauge needle inserted into the renal artery,
followed by antigen preparations in 0.5 ml volume. Blood flow was then immediately
restored to the kidney. The total ischemia time was 1-2 min. For immune complex
formation in kidneys, 1 mg of antiNAP or 1 mg of antiHSA was given intravenously 10
min after an antigen was infused into the left renal artery.
Renal biopsies were obtained at the designated times, cutting a wedge-shaped piece
from the renal cortex, approximately 3 mm x 3 mm and 3-4-mm deep. The specimens
during the first hour were obtained while the rats were under initial anesthesia. The later
specimens were obtained by open renal biopsy under anesthesia or after the rats were
sacrificed by an overdose of the anesthetic. The obtained tissue was divided for immu-
nofluorescence and electron microscopy and processed immediately.
The tissue for immunofluorescence microscopy was embedded in Tissue-Tek 11 O.C .T.
Compound (Ames Co., Elkhart, IN), quick frozen with C02, and stored at -20°C until
studied further. 6-ym sections were cut, washed, and stained with specific fluoresceinated
antibodies as previously described (1). Specific fluoresceinated goat antibodies to rabbit
IgG, human serum albumin, rat IgG, and rat C3 were employed (Kallestad Laboratories,
Chaska, MN). The presence of NAP antigenic determinants was detected by indirect
immunofluorescence, using first unconjugated, purified rabbit antibodies to NAP and
followed after washing with fluoresceinated goat antibodies to rabbit IgG.
The tissues for electron microscopy were fixed in glutaraldehyde buffered with sodium
cacodylate. They were then postfixed in 1 % buffered osmium tetraoxide and embedded
in epoxy resin. Thin sections were cut on the LKB III Ultratome, stained for 2 h with
uranyl acetate, then lead citrate for 5 min. The sections were then examined with
transmission electron microscope (Type 801 AEI Scientific Apparatus Division, Harlow,
Essex, England). A minimum of eight glomeruli were examined in each specimen.
Results
Characterization of NAP-HSA Preparations.
￿
By isoelectric focusing the cation-
ized preparations showed pI of 8 .5-10.0 (Fig. 1). Double immunodiffusion of all
three preparations showed precipitin lines with antibodies to HSA. In contrast,
precipitin lines were present only with the multivalent preparation (NAP19_7
HSAED when antibody to the NAP haptenic group was used (Fig. 2). The
oligovalent antigen preparations (NAP3.1 - HSAED and NAP, 1 .4 . HSAED) inhibited
the precipitin line with NAP 19.7-HSAED, indicating that the oligovalent antigen
preparations combined with the antibody, but were unable to form precipitates.
The cationized and noncationized preparations showed no differences by double
immunodiffusion .
To ascertain that the antigen with lowest valence (NAP3.1 -HSAED) was able to
form soluble immune complexes, an aliquot of this preparation was labeled with
131 1 and immune complexes were made with antiNAP in antibody excess, and
analyzed on sucrose density gradient. In antibody excess 25% of the radiolabeled
material was not combined with antibodies, indicating that not all molecules
carried the NAP determinants. The principal species of formed antigen-antibody
complexes had a sedimentation constant of 8 .1 Svedberg units and therefore
must have consisted of Ag,Ab, lattice (23). Complexes with sedimentation1262
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FIGURE 1 .
￿
Isoelectric focusing patterns ofhuman serum albumin and cationized precipitating
and nonprecipitating NAP -HSA preparations . Lane a shows the pattern for NAPS .,-HSAED ,
the majority of which has a pI >8.65 . In lane b, NAP, 9 . 7 . HSAFD focuses predominantly in a
pI range >8.65 ; the material present at the lower pI (7.35) is at the point of application, and
a result of poor penetration of the agarose by the highly substituted NAP -HSA . Lane r shows
the pI for unalterd HSA . Lane d shows the standards .
FIGURE 2 .
￿
Photograph of double immunodiffusion in agarose IEF of cationized and non-
cationized NAP -HSA preparations against antiNAP (center well A) . Peripheral wells contain
the following : well 1, empty ; well 2, NAPHO .HSAED; well 3, NAPS . , "HSAED; well 4, NAP S _,
HSA ; well 5, NAP,9 _ 7 -HSA ; well 6, empty. Precipitin lines form between antiNAP and both
the cationized and noncationized NAP, 9 .7-HSA preparations. The NAPS ., - HSA preparations
failed to form precipitin lines with antiNAP, but inhibited the precipitin lines formed between
antiNAP and the NAP,9.7 -HSA preparations .0. U
2.0,
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constant of 11 .7 (Ag2Ab2) and even larger complexes were present in small
amounts (Fig. 3). The NAP - HSAED preparations with higher hapten density
formed a higher proportion of large-latticed complexes at 5 times antigen excess
than the NAP3.1 - HSAED in antibody or antigen excess (data not shown).
Glomerular Localization ofAntigen Alone.
￿
The localization and persistence in
glomeruli of the cationized NAP - HSA preparations alone were defined. After
initial trials with several dosages, 600 tig of NAP3.1 - HSAED and NAP, 1 .4 .HSAED
and 400,ug NAP,9.7 .HSAED were chosen as the dosages to be examined in detail,
to assure maximum glomerular binding of the antigen. A higher dose was chosen
for the nonprecipitating NAP - HSA preparations because not all HSA molecules
carried the NAP haptenic groups, as described above. Separate groups of rats
were injected with each antigen preparation. The left kidney of each rat was
biopsied at 1 min after injection and then at additional times so that at least two
specimens were obtained from different rats at 10, 60 min, and 4, 8, 24, and 96
h after the injection of each antigen preparation. Since sequential biopsies were
obtained in all rats multiple biopsies were not obtained at each time point. The
presence of the antigens alone in glomeruli was examined by indirect immuno-
fluorescence staining for the NAP haptenic groups and by direct immunofluo-
rescence staining for HSA as the carrier molecule. With staining for the NAP
haptenic group the antigen with the lowest hapten density (NAP3.1 - HSAED)
localized and persisted in glomeruli for the shortest period of time, being 4+ at
1 min and 2+ at 10 min after antigen injection (Table 1). When stained for HSA,
the carrier molecule, this antigen persisted in glomeruli through 4 h . With
NAP, 1.4 .HSAED and NAP,9.7 -HSAED the immunofluorescent staining for NAP
haptenic groups and for the HSA gave parallel results. By 8 h these antigens had
nearly completely disappeared from glomeruli and were absent by 24 h (Table
1). With the NAP3.1 HSA in 300-pg, 400-Ag, and 1,000-mg doses the results were
similar to those indicated for the 600-mg dose in Table 1.
On the basis of these data 10 min after the infusion of the antigens into the
Per cent gradient volume
FIGURE 3. Sucrose density gradient ultracentrifugation pattern of '3'I-NAP3.,-HSAED-
antiNAP immune complexes made in antibody excess. ^-25% of free antigen is present. The
majority of theimmune complexessedimented in the 8.1 Speak,indicating Ag,Ab, complexes.
Smalleramounts of 11 .7S(Ag2Ab2) and 17.1 S complexes were also present.126 4
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TABLE I
Localization ofAntigens Alone in the Glomeruli ofthe Left Kidneys
* 600 tag ofNAP3 . 1 -HSAED or NAP11.4 -HSAEDwere injected at time t = 0 .
400wg of NAPI9.7-HSAED was injected at time t= 0 .
§Each tissue specimen was stained by indirect immunofluorescence microscopy with antiNAP
(unconjugated rabbit antiNAP and fluoresceinated goat anti-rabbit IgG) andby direct immunoflu-
orescence microscopy with antiHSA (fluoresceinated goat antiHSA) .
left renal artery was chosen as the time for intravenous administration of
antibodies to examine for formation of immune complexes in glomeruli .
Formation and Persistence of Immune Complexes in Glomeruli .
￿
Following the
injection of 600 ,ug of cationized, nonprecipitating antigens or 400 Ag of cation-
ized, precipitating antigen into the left renal artery, I mg of purified rabbit
antiNAP was injected intravenously . Separate groups of rats were used with each
antigen preparation . The left kidney of each rat was biopsied at 12 min (2 min
after antibody injection) and at additional times so that single or multiple biopsy
specimens were obtained from different rats at staggered time points at 40, 60
min and 4, 8, 24, and 96 h . The times of biopsies were staggered so that tissue
was obtained from each rat early and late in the course of the experiment . The
rats given the precipitating antigen (NAP,9 .7 -HSAED) and antiNAP showed
presence of the carrier molecule (HSA) and the antibodies (rabbit IgG) from 2
min after infusion of antibody to 96 h by immunofluorescence microscopy (Table
II, Fig . 4) . In contrast, the groups of rats given nonprecipitating antigens
(NAP 3 . 1 -HSAED or NAP, 1 .4 . HSAED ) and antiNAP showed the presence of the
antigen molecules and antibodies from 2 min after infusion of antibody to 4 h
and only small amounts of rabbit IgG at 8 h and were completely negative by 24
h and later (Table 11, Fig . 4) .
To determine that the same nonprecipitating antigens (NAP3.1 -HSAED and
NAP, 1 .4 -HSAED ) with antiNAP were able to form persisting immune deposits in
glomeruli with antibodies to the carrier molecule, purified rabbit antibodies to
human serum albumin (antiHSA) were given in the same dose after the antigen
injection to other rats and biopsied by a similar schedule as described above . In
these rats the antigen molecules and antibodies were present in glomeruli by
immunofluorescence microscopy from 2 min through 96 h afterantibody admin-
istration (Table II) .
The injection of antiNAP or antiHSA alone into rats without prior antigen
administration caused no glomerular deposits by immunofluorescence micros-
copy with antibodies to rabbit IgG .
All renal biopsies were also stained with goat antibodies to rat IgG and no
Time of biopsy
NAPs , 1-HSAED*
AntiNAP§ AntiHSA
NAP . 4.HSAED*
AntiNAP AntiHSA
NAP19.7.HSAED'
AntiNAP AntiHSA
1 min 4+ 4+ 4+ 3.5+ 4+ 3+
10 min 2+ 4+ 3+ 2+ 4+ 2+
60 min 0 2.5+ ± 1 .5+ 3.5+ 2.5+
4 h 0 3+ 0 1+ 3+ 1+
8h 0 0 0 0 1+ ±
24h 0 0 0 0 0 0
96h 0 0 0 0 0 0AGODOA ET AL.
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TABLE II
GlomerularPresence ofRabbit IgG and HSA After Injection ofNonprecipitating or Precipitating
Antigens, Followed by Administration ofAntibodies*
Discussion
*Alltissue specimenswere stained with fluoresceinated goat anti-rabbit IgG;the resultsare given in
columns designated Ab, and stained with fluoresceinated goat antiHSA; the results are given in
columnsdesignated Ag.
$Rats were given 600 Ag of theantigen into left renal artery and 10 min later 1 mg of antibodies
intravenously.
§Rats were given 400 ug of the antigen into left renal artery and 10 min later 1 mg of antibodies
intravenously.
deposits were found at any time point in the described experiments. Similar
staining was also performed with goat antibodies to rat C3, only the specimens
with persistent presence of antigen and antibody at 96 h showed trace amounts
ofrat C3.
Transmission electron microscopy was carried out on selected specimens of
renal tissues to determine the presence and location ofelectron-dense deposits.
In rats given the nonprecipitatingantigens (NAPS., - HSAEDand NAP, 1.4 -HSAED)
and antiNAP, electron-dense deposits could not be found at 40 min or 60 min
(Fig. 5), even though the antigen and antibodies were present by immunofluo-
rescence microscopy (Table II). In contrast, in glomeruli of rats given the
precipitating antigen (NAP 19.7 .HSAED) and antiNAP, electron-dense deposits
were found as early as the 40-min time point, at which time the loose deposits
were largely in the subendothelial and mesangial areas, with sparse subepithelial
deposits. By 4 h, the electron-dense deposits were principally in the subepithelial
area, with occasional mesangial deposits. By 24 and 96 h, only subepithelial
electron-dense deposits were present (Figs. 5 and 6). Also in rats given the
nonprecipitating NAP-HSA preparations, followed by antibodies to HSA, sub-
epithelial deposits were present at 24 h and 96 h. These deposits were identical
to the deposits found in rats given the precipitating NAP-HSA preparation and
antiNAP at the same time points.
The presented data indicate that precipitating antigen-antibody systems are
essential for the persistence of immune complexes by immunofluorescence mi-
croscopy and the formation ofelectron-dense immune deposits in the subepithe-
lial area of glomeruli. With nonprecipitating antigen-antibody systems immune
Rats given antiNAP afterantigen Rats given antiHSA after antigen
Time
of bi- NAPs. 1 . HSAED NAP11 .4- HSAED NAP19.7'
HSAED§ NAPs.1 -HSAED
NAP,1.4*
HSAED$ opsy
Ab Ag Ab Ag Ab Ag Ab Ag Ab Ag
12 min 4+ 4+ 3+ 3+ 4+ 4+ 4+ 4+ 4+ 4+
40 min 4+ 4+ 3+ 3+ 3.5+ 4+ 4+ 4+ 3.5+ 3+
60 min 3+ 3+ 3+ 2+ 3+ 3+ 4+ 4+ 3+ 3+
4 h 2.5+ 2+ 2.5+ 1+ 3+ 3+ 3+ 3+ 3+ 3+
8 h ± 0 1+ 0 3.5+ 3+ 4+ 2.5+ 3+ 2+
24 h 0 0 0 0 3+ 3+ 3+ 2+ 2.5+ 2+
96 h 0 0 0 0 3+ 2+ 3+ 2+ 2.5+ 2+1266
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FIGURE 4.
￿
Photomicrographs of glomerular immunofluorescence after staining with fluores-
ceinated antibody to rabbit IgG in rats that received cationized NAP -HSA in left renal artery
followed by intravenous infusion ofantiNAP at 10 min . Renal biopsy specimens are illustrated
for I h and 96 h . At the 1 h time point all preparations showed strongly positive staining for
rabbit IgG . By 96 h, rabbit IgG could not be detected in the kidneys of the animals that
received cationized, nonprecipitating NAP -HSA . On the other hand, the animals that received
cationized, precipitatingNAP-HSA showed strongly positive staining for rabbit IgG at 96h .
complexes formed in glomeruli as determined by immunofluorescence, but these
complexes were present only transiently, comparable to the antigen molecules
alone, and electron-dense deposits did not evolve in glomeruli with these prepa-
rations .
The infusion of antigens alone demonstrated that the cationized NAP -HSA
preparations were readily planted in glomeruli due to interaction with the fixed
negative charges, that have been demonstrated in the lamina rara interna and in
the lamina rara externa of the glomerular basement membrane (6). The presence
of antigen molecules was demonstrated by immunofluorescence microscopy with
antibodies to the hapten and with antibodies to the carrier molecule . By staining
with antibodies to the hapten, the NAPS ., -HSA preparation was present in1267
FIGURE 5 .
￿
Electron photomicrographs of the glomerular capillary basement membrane in
rats injected with cationized NAP-HSA preparations into the left renal artery, followed by
antiNAP intravenously at 10 min . In panel A the rat received NAP3 .,-HSAED followed by
antiNAP and renal biopsy was taken at 60 min . No electron-dense deposits are seen . In panel
Bthe rat received NAP,9 ., -HSAED followed by antiNAP and renal biopsy was taken at 60 min .
Prominent, loose subendothelial deposits (arrows) are seen, with loss of endothelial cell
fenestrae . In panel C the rat received NAP,9.7 "HSAED followed by antiNAP, and biopsy was
taken at 96h. Prominent electron dense deposits (arrows) are seen in the subepithelial region .
US, urinary space; EC, endothelial cell ; CL, capillary lumen ; PMN, polymorphonuclear leuko-
cyte . A-C, x 19,000 .
glomeruli at 1 min and 10 min after injection into the renal artery . The staining
of the tissues with antibodies to carrier molecules, however, disclosed that the
injected material was present longer and became undetectable by 8 h after
injection . The difficulty in detection of the antigen molecules with antibodies to
NAPwasattributed to the low valence of the antigen . With higher hapten density
on HSA (NAP., . HSAED and NAP, 9_7 "HSAED), the presence of the injected
molecules could be detected in comparable manner with antibodies to the hapten
or with antibodies to the carrier molecule . Because of this apparently short
presence of the haptenic determinants with NAPS,, -HSAED , 10 min was chosen
as the time for injection of the antibodies to NAPdeterminants in allexperiments .1268
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FIGURE 6 .
￿
Electron photomicrograph of the glomerular mesangium in a rat injected with
NAP,9.,-HSAEO into the left renal artery followed by antiNAP, and the kidney biopsy was
taken at I h. Prominent electron dense deposits are seen in the mesangium (thick arrows) as
well as in the subepithelial areas (thin arrows) . CL, capillary lumen; US, urinary space. X
19,000 .
The persistence of the cationized antigens alone in glomeruli was comparable to
findings by previous investigators ; for example Oite et al . (13) determined that
the half-life of cationized human IgG was 4.2 h in glomeruli of rats .
The conclusion that immune complexes were actually formed in glomeruli
when NAPS,, -HSAED or NAP, 1 .4 .HSAED were injected and followed with anti-
bodies to NAP, was based on several observations . First, even though these
antigens were nonprecipitating, soluble immune complexes were formed when
radiolabeled antigens were mixedwith antibodiesand analyzed on sucrosedensity
gradients . In the NAP3 _ 1 -HSAED preparations 25% ofthe molecules didnot react
with antINAP in antibody excess, either because this proportion ofHSA mole-
cules was not conjugated with the hapten or because the fomred complexes
dissociated during the separation on sucrose density gradient due to low avidity.
It is unlikely that from this preparation the cationized HSA molecules preferen-
tially interacted with the fixed negative charges in glomeruli . Second, after the
administration of antibodies to NAP, both the antibody and antigen molecules
were detected by immunofluorescence microscopy for comparable duration .
Finally, the injection of NAP, 1 .4 .HSAED followed by antiNAP at the same time
intervals showed comparable results (Table II). This average number of hapten
groups per carrier molecule was chosen to bring the antigen close to a precipi-
tating system with antibodies to the hapten, since previous studies showed that
when the average number of NAP groups per carrier molecule was 12.9 or
higher, a precipitating antigen-antibody system was generated (16) .
The administration of antibodies to the carrier molecule after the injection of
theNAPS . , -HSAED or NAP, 1 .4
- HSAED showed that these molecules were planted
in a manner comparable with the precipitating NAP,9 .7 .HSAEDsystem since with
antibodies to HSA the deposits persisted by immunofluorescence microscopy andAGODOA ET AL.
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electron-dense deposits were formed in subepithelial areas of glomeruli.
The persistence of a precipitating antigen-antibody system in glomeruli and
the formation ofsubepithelial electron-dense deposits wasdemonstrated with the
precipitating NAP,9_7-HSAED and antiNAP system and by injection ofantibodies
to the carrier protein with the nonprecipitating hapten-carrier conjugates. The
sequence of electron-dense deposit formation was studied in detail with the
NAP,9.7- HSAED and antiNAP system. Already at 40 min electron-dense deposits
were noted in the subendothelial and mesangial areas, but these deposits were
relatively loose in character. Presumably these subendothelial deposits were
formed when injected antibodies combined with the cationized antigen that had
interacted with the fixed negative charges in the lamina rara interna. At 40 min
only sparse subepithelial deposits were found. By 4 h the electron-dense deposits
were principally in the subepithelial area and at 24 and 96 h these deposits were
only in the subepithelial area. This sequence of development of electron-dense
deposits indicates that if similar deposits had formed with the nonprecipitating
antigen-antibody systems, the deposits should have been detected. The build-up
of subepithelial immune deposits may involve two mechanisms, as discussed by
Vogt et al. (14). First, antigens of appropriate molecular size may plant both in
the lamina rara externa and lamina rara interna and then form immune com-
plexes in both locations with antibodies reaching these locations from the
circulation. Second, immune deposits may initially form in the subendothelial
area and then dissociate into smaller complexes or even free antibodies and
antigens and these small complexes or free antibodies may pass through the
lamina densa to form immune complexes in the subepithelial area and condense
into immune deposits. These two possible mechanisms are consistent with the
presented results and the available information does not distinguish between
these alternatives. The observed sequence of development of electron-dense
deposits with the precipitating antigen-antibody systems was comparable to the
sequence with cationized ferritin and antibodies to ferritin (14).
The mechanism by which cationized antigen molecules are removed from the
subepithelial areas ofglomeruli is not known at this time. Ofinterest is that small
antigen-antibody complexes are removed from this area in a similar time period,
and therefore possibly by the same unknown mechanism.
In a previous investigation we concluded that circulating immune complexes
must undergo condensation or rearrangement after the initial attachment to
glomeruli to form electron-dense deposits in subendothelial or mesangial areas
ofglomeruli in mice (4). Thus, in conjunction with the data presented here the
conclusion can be reached that the formation ofelectron-dense immune deposits
in the glomeruli, i.e. in subendothelial, mesangial, or subepithelial area, requires
precipitating antigen-antibody systems. This information should be useful in the
identification of antigen-antibody systems that cause glomerulonephritis in hu-
mans associated with the presence of electron-dense immune deposits. The
relatively transient presence ofimmune complexes thatcan notform precipitates
is detectable by immunofluorescence microscopy by staining for antibodies or
for antigens, but can not be recognized by routine electron microscopy. The
ability of these transient, smaller immune complexes to induce inflammation or1270
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to cause damage by complement activation in the subepithelial area have not
been examined.
Summary
This study was conducted to determine whether multivalent, precipitating
antigens are required for formation of subepithelial electron-dense immune
deposits in glomeruli .
2-nitro-4-azidophenyl (NAP) was conjugated with variable density to human
serum albumin (HSA) to yield nonprecipitating (NAPS., .HSA and NAP11.4
HSA) and precipitating (NAP,9.7 . HSA) antigens with antibodies to the hapten.
These antigen preparations were cationized with ethylene diamine to enhance
deposition in renal glomeruli due to interaction with the fixed negative charges
in the glomerular capillary wall . Following injection into the left renal artery of
rats these antigens alone persisted in the glomeruli for a relatively short time by
immunofluorescence microscopy. When antibodies to NAP were injected intra-
venously after the antigen injection, the nonprecipitating antigens and antibodies
were detectable in the glomeruli by immunofluorescence microscopy up to 8 h,
comparable to antigen alone . Electron-dense deposits were not formed in these
glomeruli. In contrast, when the precipitating antigen was injected and followed
by antibodies to the hapten, antigen and antibody were detected by immunoflu-
orescence microscopy through 96 h. In these specimens electron-dense deposits
were present from 40 min through 96 h and after 24 h the deposits were present
only in the subepithelial area. The same results were obtained when the nonpre-
cipitating hapten-carrier conjugates were followed with antibodies to the carrier
molecule. These data indicate that the persistence of immune deposits by im-
munofluorescence microscopy and the formation of electron-dense deposits in
the subepithelial area require a precipitating antigen-antibody system.
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secretarial assistance.
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